unknown
Stage
About
Amarin is a global pharmaceutical company focused on developing and commercializing therapies to reduce cardiovascular disease, including their approved product VASCEPA.
Explore Amarin's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.